ADMA · Adma Biologics, Inc. · Metrics
$13.36
+0.02 (+0.15%)
At close · Nov 20
Return incl. dividend (before tax)
Play latest call
Q2 2026 earnings call transcript
Market Cap
$2.96B
Shares
221.85M
Volume · Nov 20
284.76K
Avg daily vol (3M)
3.2M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
ADMA metrics
113 of 125 screener metrics currently available.
Market overview
2 metricsShare price
$13.34
Market cap
$2.96B
Price action
23 metricsPrice change (1W)
+0.8%
Price change (30D)
+21.2%
Price change (3M)
+36.7%
Price change (6M)
+57.7%
Price change (YTD)
-26.9%
Price change (1Y)
-16.4%
Trailing year
Price change (5Y)
+771.9%
52-week high
$20.38
52-week low
$7.60
Change from 52-week high
-34.5%
Change from 52-week low
+75.5%
Annualized volatility
58.9%
Annualized volatility (3M)
64.3%
Implied volatility (30D)
50.4%
IV rank (1Y)
15.5
IV percentile (1Y)
11.4
Beta
-0.1
RSI (14D)
64.7
Price vs SMA 50
+22.4%
Price vs SMA 200
+25.2%
Avg volume (3M)
3.20M
Relative volume
1.1
Average dollar volume
$34.62M
Company
3 metricsSector
Healthcare
Industry
Biotechnology
Shares outstanding
221.85M
Valuation
12 metricsP / E (TTM)
17.3
Trailing earnings · reciprocal yield 5.8%
PEG ratio
0.4
EV / revenue
5.8×
reciprocal yield 17.1%
EV / EBITDA
12.2×
reciprocal yield 8.2%
EV / EBIT
12.6×
reciprocal yield 8.0%
P / sales
5.7×
reciprocal yield 17.5%
P / book
6.7
reciprocal yield 14.8%
FCF yield
4.5%
TTM · current market cap
Buyback yield
6.4%
P / FCF
22.3
reciprocal yield 4.5%
P / operating cash flow
21.0
reciprocal yield 4.8%
Earnings yield
6.2%
Historical valuation
8 metricsP / E historical average (3Y)
31.6×
reciprocal yield 3.2%
P / E historical average (5Y)
31.6×
reciprocal yield 3.2%
EV / revenue historical average (3Y)
5.7×
reciprocal yield 17.7%
EV / revenue historical average (5Y)
5.3×
reciprocal yield 18.7%
EV / EBIT historical average (3Y)
14.4×
reciprocal yield 6.9%
EV / EBIT historical average (5Y)
14.4×
reciprocal yield 6.9%
EV / EBITDA historical average (3Y)
13.8×
reciprocal yield 7.2%
EV / EBITDA historical average (5Y)
13.8×
reciprocal yield 7.2%
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
6.4%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
2026-11-04
Profitability
9 metricsGross margin
68.5%
Operating margin
46.5%
Trailing 12 months
Net margin
35.1%
Gross profit (TTM)
$355.76M
Operating profit (TTM)
$241.23M
Net income (TTM)
$182.41M
Trailing 12 months
Diluted EPS (TTM)
$0.77
FCF margin
25.6%
Effective tax rate
22.2%
Growth
11 metricsRevenue growth YoY
+5.1%
Year over year
Net income growth YoY
+36.9%
Revenue (TTM)
$519.15M
Trailing 12 months
EPS growth YoY
+46.7%
Shares change YoY
-7.7%
Year over year · fewer shares
Revenue CAGR (3Y)
+49.0%
Revenue CAGR (5Y)
+64.6%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
41.6%
Return on assets
24.9%
Debt / equity
0.4
Current ratio
6.0
EBITDA (TTM)
$248.68M
Free cash flow (TTM)
$132.91M
Quick ratio
3.3
Interest coverage
22.8
Net debt / EBITDA
0.3
Return on invested capital
36.8%
Trailing 12 months
Net cash
−$71.30M
Latest balance sheet
Cash & equivalents
$124.56M
Total assets
$732.49M
Total debt
$195.86M
Cash flow & spend
7 metricsOperating cash flow (TTM)
$140.79M
Capital expenditures (TTM)
$7.88M
R&D (TTM)
$14.48M
SG&A (TTM)
$103.55M
Stock compensation (TTM)
$24.06M
R&D / revenue
2.8%
Stock compensation / revenue
4.6%
Ownership (13F)
9 metrics13F filers
330
13F filer change QoQ
+8
Institutional ownership
90.5%
Conviction holders (share of 13F filers)
0.9%
Crowding (high-turnover and private-fund holders)
31.3%
Private-fund adviser ownership
26.5%
Active holders' share change QoQ
+4.6%
Holder tenure
11.9
Price vs estimated holder cost
-14.3%
Ownership (registered funds)
1 metricsIndex-fund ownership
34.7%
Short interest
3 metricsShort interest
8.1%
Latest settlement · 7.1 days to cover
Days to cover
7.1d
Short-squeeze score
75 / 100
Insider activity
2 metricsNet insider buying (90D)
−$2.19M
Insider-sentiment score
46 / 100
Risk flags
1 metricsGoing concern
—
Key facts
CIK
1368514
CUSIP
000899104
13F (30d)
333 filings
305 filers
Visit website
Investor relations